Home Cart Sign in  
Chemical Structure| 57115-24-9 Chemical Structure| 57115-24-9
Chemical Structure| 57115-24-9

*Storage: Inert atmosphere,Room Temperature.

3-Oxo-2-(pyridin-2-yl)butanenitrile

CAS No.: 57115-24-9

4.5 *For Research Use Only !

Cat. No.: A184744 Purity: 95%

Change View

Size Price

USA Stock *0-1 Day

Global Stock *5-7 Days

In Stock
1g łÇòǶÊÊ Inquiry 1-2 weeks Login

Please Login or Create an Account to: See VIP prices and availability

  • 1g

    łÇòǶÊÊ

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Product Details of [ 57115-24-9 ]

CAS No. :57115-24-9
Formula : C9H8N2O
M.W : 160.17
SMILES Code : CC(C(C1=NC=CC=C1)C#N)=O
MDL No. :MFCD23713812
InChI Key :ZKSFBSZAPWNWFK-UHFFFAOYSA-N
Pubchem ID :331541

Safety of [ 57115-24-9 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Calculated chemistry of [ 57115-24-9 ] Show Less

Physicochemical Properties

Num. heavy atoms 12
Num. arom. heavy atoms 6
Fraction Csp3 0.22
Num. rotatable bonds 2
Num. H-bond acceptors 3.0
Num. H-bond donors 0.0
Molar Refractivity 43.57
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

53.75 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.02
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

0.5
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

1.28
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-0.19
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

1.66
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.85

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-1.39
Solubility 6.58 mg/ml ; 0.0411 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-1.2
Solubility 10.1 mg/ml ; 0.0633 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.48
Solubility 0.526 mg/ml ; 0.00328 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.92 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.05

Application In Synthesis [ 57115-24-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 57115-24-9 ]

[ 57115-24-9 ] Synthesis Path-Upstream   1~1

  • 1
  • [ 2739-97-1 ]
  • [ 75-36-5 ]
  • [ 57115-24-9 ]
YieldReaction ConditionsOperation in experiment
29% With sodium ethanolate In tetrahydrofuran at 10℃; for 16 h; [507] To a solution of 2-(2-pyridyl)acetonitrile (2,00 g, 16,93 mmol, 1.83 mL, 1 ,00 eg) in THF (5 mL) was added EtONa (3.46 g, 50.79 mmol, 3.00 eg) and formyl chloride (2.18 g, 33.86 mmol, 2.00 eg). The reaction mixture was stirred at 10 °C for 16 h. TLC (ethyl acetate) indicated -40percent of SM remained and one major new spot formed. The reaction mixture was diluted with water (50 mL), and adjusted to pH=5 with sat. aq. KHSO4 solution. Then the resulting mixture was extracted with ethyl acetate (50 mL χ 3). The organic layers were combined, dried over anhydrous NazSC , filtered and concentrated under reduced pressure to give a residue, which was purified by column chromatography on silica gel (5- 50percent ethyl acetate/petroleum ether) to afford 3-oxo-2-(2-pyridyl)butanenitrile (780 mg, 4.87 mmol, 29percent yield) as a yellow solid. LC-MS (ESI): m/z 161.0 { .M 1 I s ' .
References: [1] Patent: WO2017/210678, 2017, A1, . Location in patent: Paragraph 506; 507.
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 57115-24-9 ]

Ketones

Chemical Structure| 6302-02-9

A109021 [6302-02-9]

1-(Pyridin-2-yl)propan-2-one

Similarity: 0.79

Chemical Structure| 54123-21-6

A109017 [54123-21-6]

3-Oxo-3-(pyridin-2-yl)propanenitrile

Similarity: 0.79

Chemical Structure| 22971-32-0

A284972 [22971-32-0]

2-Butyrylpyridine

Similarity: 0.72

Chemical Structure| 28566-14-5

A245782 [28566-14-5]

6,7-Dihydrocyclopenta[b]pyridin-5-one

Similarity: 0.70

Chemical Structure| 1721-12-6

A271944 [1721-12-6]

1-(2-Methylpyridin-3-yl)ethanone

Similarity: 0.69

Nitriles

Chemical Structure| 54123-21-6

A109017 [54123-21-6]

3-Oxo-3-(pyridin-2-yl)propanenitrile

Similarity: 0.79

Chemical Structure| 1018949-67-1

A131593 [1018949-67-1]

2-(3-Aminopyridin-2-yl)acetonitrile

Similarity: 0.68

Chemical Structure| 38203-08-6

A450564 [38203-08-6]

2-(5-Methylpyridin-2-yl)acetonitrile

Similarity: 0.68

Chemical Structure| 5912-34-5

A256432 [5912-34-5]

3-(Cyanomethyl)picolinonitrile

Similarity: 0.66

Chemical Structure| 170734-10-8

A112923 [170734-10-8]

1-(Pyridin-3-yl)cyclopropanecarbonitrile

Similarity: 0.64

Related Parent Nucleus of
[ 57115-24-9 ]

Pyridines

Chemical Structure| 6302-02-9

A109021 [6302-02-9]

1-(Pyridin-2-yl)propan-2-one

Similarity: 0.79

Chemical Structure| 54123-21-6

A109017 [54123-21-6]

3-Oxo-3-(pyridin-2-yl)propanenitrile

Similarity: 0.79

Chemical Structure| 22971-32-0

A284972 [22971-32-0]

2-Butyrylpyridine

Similarity: 0.72

Chemical Structure| 90563-75-0

A493792 [90563-75-0]

2-(Pyridin-2-yl)cyclopropanecarboxylic acid

Similarity: 0.70

Chemical Structure| 1721-12-6

A271944 [1721-12-6]

1-(2-Methylpyridin-3-yl)ethanone

Similarity: 0.69